Publication & Citation Trends
Publications
0 total
Outcomes and immune response after peptide vaccination targeting human cytomegalovirus antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma.
Cited by 5
Semantic Scholar
Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.
Cited by 8
Semantic Scholar
EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL OA
Cited by 3
Semantic Scholar
IMMU-04. VACCINATING AGAINST NOVEL CYTOMEGALOVIRUS ANTIGENS IN GLIOBLASTOMA USING A PEPTIDE VACCINE IN COMBINATION WITH TEMOZOLOMIDE OA
Cited by 1
Semantic Scholar
Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
Cited by 10
Semantic Scholar
Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells. OA
Cited by 37
Semantic Scholar
Tumor stem cell RNA-loaded dendritic cell vaccine for recurrent glioblastoma: a phase 1 trial (S41.004)
Cited by 6
Semantic Scholar
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy OA
Cited by 6
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(16)
Glioma Diagnosis and Treatment
(15)
CAR-T cell therapy research
(8)
RNA Interference and Gene Delivery
(7)
Cancer Immunotherapy and Biomarkers
(6)
Affiliations
The University of Texas MD Anderson Cancer Center
Emory University
Duke University
University of California, San Francisco
GTx (United States)